With the tax treatment of endowment plans changing recently, we take a look at whether there is any merit left in buying one of these plans.
Is there still a case for buying an endowment plan? Read More »
Short-term technical outlook for the Nifty 50 and a closer look at some outperforming sectors in this technical outlook.
Technical outlook: Nifty 50’s short-term trend Read More »
Long term rates have spiked again and so, in this Prime debt strategy, we tell you which opportunities you should be locking into.
Prime debt strategy: Time to enter this duration category Read More »
The JP Morgan India inclusion finally happened and with effect from June 28, 2024, Indian G-secs will be included in JP Morgan’s GBI-EM Global Diversified Index. What does this mean and how does it impact you as a debt investor?
JP Morgan India inclusion: What it means for Indian g-secs Read More »
Recent announcements relating to ownership change in this pharma stock prompt us to move this stock from a ‘BUY’ to a ‘HOLD’.
Prime Stock alert: Moving this pharma stock to a HOLD Read More »
A report from Kotak Institutional Equities sparked a bout of selling in mid and small caps. Should you be concerned? Here is what we think.
Mid and small cap stocks – is it time to exit? Read More »
How to fine-tune your portfolio using Prime Portfolio Review Pro tool
4 steps to improving your MF portfolio performance Read More »
While long-term returns are the best when analysing mutual fund performance,
there are certain situations where short-term returns become important.
4 reasons why short term returns matter for MFs Read More »
results update for 5 of our Prime Stocks
Results update 1 – for quarter ending June 2023 Read More »
What stock markets should be assessed on, where markets stand now, and other observations.
There is greed in the air Read More »
And is there further downside possibility in the short-term?
Technical outlook – Has the Nifty 50 topped out? Read More »
The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research services before onboarding. History, Present business and Background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services. Terms and conditions of Research Services: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Analyst never guarantees the returns on the recommendation provided. Investor shall take note that Investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The Research Analyst shall not be responsible for any loss to the Investors. Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made there under against the Research Analyst relating to Research Analyst services. Details of its associates: No associates. Disclosures with respect to Research and Recommendations Services: The Research Analyst or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of Research Analyst services. Such conflict of interest shall be disclosed to the client as and when they arise. Research Analyst or its directors or its employee or its associates have not received any compensation from the company which is subject matter of recommendation. Research Analyst or its directors or its employee or its associates have not managed or co-managed the public offering of any company. Research Analyst or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation. The subject company was not a client of Research Analyst or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided. Research Analysts or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.
Full disclosures and disclaimers
Compliance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
Grievance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
